D. K. Chitkara

798 total citations
18 papers, 566 citations indexed

About

D. K. Chitkara is a scholar working on Gastroenterology, Rheumatology and Surgery. According to data from OpenAlex, D. K. Chitkara has authored 18 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Gastroenterology, 6 papers in Rheumatology and 5 papers in Surgery. Recurrent topics in D. K. Chitkara's work include Gastrointestinal motility and disorders (7 papers), Gastroesophageal reflux and treatments (5 papers) and Spondyloarthritis Studies and Treatments (5 papers). D. K. Chitkara is often cited by papers focused on Gastrointestinal motility and disorders (7 papers), Gastroesophageal reflux and treatments (5 papers) and Spondyloarthritis Studies and Treatments (5 papers). D. K. Chitkara collaborates with scholars based in United States, Russia and Germany. D. K. Chitkara's co-authors include Filippo Cremonini, Heiko U. De Schepper, Michael Camilleri, Miranda A.L. van Tilburg, Mazurov Vi, Nathan Vastesaeger, L. Myasoutova, Yeong Wook Song, Jan Lenaerts and J. Wollenhaupt and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases and Alimentary Pharmacology & Therapeutics.

In The Last Decade

D. K. Chitkara

18 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. K. Chitkara United States 10 248 207 144 142 64 18 566
Sara Isoldi Italy 14 113 0.5× 48 0.2× 195 1.4× 48 0.3× 26 0.4× 44 482
Dan Atkins United States 22 85 0.3× 449 2.2× 927 6.4× 116 0.8× 136 2.1× 56 1.4k
Bethany Doerfler United States 17 250 1.0× 549 2.7× 856 5.9× 120 0.8× 53 0.8× 35 1.2k
M.-A. Wallander Sweden 7 141 0.6× 81 0.4× 166 1.2× 37 0.3× 23 0.4× 9 475
M. A. Benninga Netherlands 17 471 1.9× 111 0.5× 413 2.9× 16 0.1× 104 1.6× 57 847
Lori Mahajan United States 14 222 0.9× 47 0.2× 319 2.2× 29 0.2× 31 0.5× 49 681
Matthew Clark United States 10 153 0.6× 48 0.2× 130 0.9× 9 0.1× 38 0.6× 27 398
J. A. J. M. Taminiau Netherlands 10 382 1.5× 100 0.5× 379 2.6× 14 0.1× 63 1.0× 30 604
J. A. J. M. Taminiau Netherlands 12 335 1.4× 118 0.6× 383 2.7× 7 0.0× 160 2.5× 35 662
Grazia Di Leo Italy 11 196 0.8× 23 0.1× 159 1.1× 12 0.1× 43 0.7× 47 413

Countries citing papers authored by D. K. Chitkara

Since Specialization
Citations

This map shows the geographic impact of D. K. Chitkara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. K. Chitkara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. K. Chitkara more than expected).

Fields of papers citing papers by D. K. Chitkara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. K. Chitkara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. K. Chitkara. The network helps show where D. K. Chitkara may publish in the future.

Co-authorship network of co-authors of D. K. Chitkara

This figure shows the co-authorship network connecting the top 25 collaborators of D. K. Chitkara. A scholar is included among the top collaborators of D. K. Chitkara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. K. Chitkara. D. K. Chitkara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Danese, Silvio, Jean‐Frédéric Colombel, Terry Ponich, et al.. (2022). DOP44 Long-term use of ozanimod in patients with moderately to severely active Ulcerative Colitis. Journal of Crohn s and Colitis. 16(Supplement_1). i093–i094. 4 indexed citations
2.
Tatosian, Daniel, Jim X Shen, Nathan S. Teuscher, et al.. (2021). P315 Population pharmacokinetics and pharmacodynamics of ozanimod in ulcerative colitis. Journal of Crohn s and Colitis. 15(Supplement_1). S341–S342. 1 indexed citations
3.
Danese, Silvio, Markus F. Neurath, Salam Zakko, et al.. (2018). OP006 Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study. Journal of Crohn s and Colitis. 12(supplement_1). S004–S005. 19 indexed citations
4.
5.
Sieper, Joachim, Jan Lenaerts, J. Wollenhaupt, et al.. (2013). Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1. Annals of the Rheumatic Diseases. 73(1). 101–107. 147 indexed citations
6.
Sieper, Joachim, Jan Lenaerts, J. Wollenhaupt, et al.. (2013). Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. Annals of the Rheumatic Diseases. 73(1). 108–113. 42 indexed citations
7.
Sieper, J., Martín Rudwaleit, Jan Lenaerts, et al.. (2013). FRI0424 Role of baseline c-reactive protein in response to infliximab plus naproxen vs naproxen alone in patients with axial spondyloarthritis in the infast study. Annals of the Rheumatic Diseases. 72. A518–A518. 1 indexed citations
8.
9.
10.
Cheng, Yufeng, L. Zhang, Baohui Han, et al.. (2011). The effect of a 3-day oral aprepitant regimen on the prevention of CINV over standard therapy in Chinese patients receiving high-dose cisplatin.. Journal of Clinical Oncology. 29(15_suppl). 9105–9105. 2 indexed citations
11.
Choung, Rok Seon, Megan E. Branda, D. K. Chitkara, et al.. (2010). Longitudinal direct medical costs associated with constipation in women. Alimentary Pharmacology & Therapeutics. 33(2). 251–260. 42 indexed citations
12.
Tilburg, Miranda A.L. van, Desmond K. Runyan, Adam J. Zolotor, et al.. (2010). Unexplained Gastrointestinal Symptoms After Abuse in a Prospective Study of Children at Risk for Abuse and Neglect. The Annals of Family Medicine. 8(2). 134–140. 63 indexed citations
13.
Tilburg, Miranda A.L. van & D. K. Chitkara. (2010). The clinical approach to chronic abdominal pain and irritable bowel syndrome in children.. PubMed. 62(2). 179–87. 2 indexed citations
14.
Chitkara, D. K. & Carlo DiLorenzo. (2006). Pharmacotherapy for functional gastrointestinal disorders in children. Current Opinion in Pharmacology. 6(6). 536–540. 7 indexed citations
15.
Chitkara, D. K. & Peter L. Lu. (2006). From the bench to the ‘crib’‐side: implications of scientific advances to paediatric neurogastroenterology and motility. Neurogastroenterology & Motility. 18(4). 251–262. 14 indexed citations
16.
Chitkara, D. K., Albert J. Bredenoord, Mary Jo Rucker, & Nicholas J. Talley. (2005). Aerophagia in adults: a comparison with functional dyspepsia. Alimentary Pharmacology & Therapeutics. 22(9). 855–858. 37 indexed citations
17.
Chitkara, D. K., et al.. (2005). Aerophagia in children: characterization of a functional gastrointestinal disorder. Neurogastroenterology & Motility. 17(4). 518–522. 15 indexed citations
18.
Schepper, Heiko U. De, Filippo Cremonini, D. K. Chitkara, & Michael Camilleri. (2004). Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterology & Motility. 16(3). 275–285. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Isoldi Breakdown of academic impact, for papers by Dan Atkins Breakdown of academic impact, for papers by Bethany Doerfler Breakdown of academic impact, for papers by M.-A. Wallander Breakdown of academic impact, for papers by M. A. Benninga Breakdown of academic impact, for papers by Lori Mahajan Breakdown of academic impact, for papers by Matthew Clark Breakdown of academic impact, for papers by J. A. J. M. Taminiau Breakdown of academic impact, for papers by J. A. J. M. Taminiau Breakdown of academic impact, for papers by Grazia Di Leo
Rankless by CCL
2026